376 related articles for article (PubMed ID: 1346166)
1. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
Remaury A; Paris H
J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Langin D; Paris H; Lafontan M
Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
[TBL] [Abstract][Full Text] [Related]
3. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
4. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
5. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
6. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa.
Valet P; Senard JM; Devedjian JC; Planat V; Salomon R; Voisin T; Drean G; Couvineau A; Daviaud D; Denis C
J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045
[TBL] [Abstract][Full Text] [Related]
7. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
[TBL] [Abstract][Full Text] [Related]
8. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
9. Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells.
Senard JM; Langin D; Estan L; Paris H
Eur J Pharmacol; 1990 Nov; 191(1):59-68. PubMed ID: 1982658
[TBL] [Abstract][Full Text] [Related]
10. Coupling of the alpha 2-adrenergic receptor to the inhibitory G-protein Gi and adenylate cyclase in HT29 cells.
Remaury A; Larrouy D; Daviaud D; Rouot B; Paris H
Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):283-8. PubMed ID: 8099279
[TBL] [Abstract][Full Text] [Related]
11. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
Galitzky J; Larrouy D; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
[TBL] [Abstract][Full Text] [Related]
12. Imidazoline binding sites in fat cells. Localization and pharmacologic differentiation from alpha 2-adrenergic receptors.
Lafontan M; Langin D; Portillo M; Paris H
Am J Hypertens; 1992 Apr; 5(4 Pt 2):72S-79S. PubMed ID: 1350731
[TBL] [Abstract][Full Text] [Related]
13. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
Wallace DR; Muskardin DT; Zahniser NR
Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
[TBL] [Abstract][Full Text] [Related]
15. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
16. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
[TBL] [Abstract][Full Text] [Related]
17. [3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors.
Langin D; Lafontan M; Stillings MR; Paris H
Eur J Pharmacol; 1989 Aug; 167(1):95-104. PubMed ID: 2570706
[TBL] [Abstract][Full Text] [Related]
18. Imidazolinic radioligands for the identification of hamster adipocyte alpha 2-adrenoceptors.
Saulnier-Blache JS; Carpéné C; Langin D; Lafontan M
Eur J Pharmacol; 1989 Nov; 171(2-3):145-57. PubMed ID: 2575998
[TBL] [Abstract][Full Text] [Related]
19. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
Evans RG; Haynes JM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between alpha 2-adrenoceptors and [3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells.
Langin D; Paris H; Dauzats M; Lafontan M
Eur J Pharmacol; 1990 Apr; 188(4-5):261-72. PubMed ID: 1973120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]